ABSTRACT
Objectives: To forecast the monetary impact by using Return on Investment (ROI) when integrating the World Health Organization (WHO) patient safety curriculum within the two years of an active diploma duration for 2019 and 2021 classes based on reported Hospital-Acquired Pressure Ulcers (HAPU) events. Methods: During this cross-sectional study, we compared the financial impact of integrating the WHO Patient Safety Curriculum in one 2-year diploma program in Saudi Hospital for class 2019 and 2021. All 51 qualified students were identified and included in this study. Demographic and patient safety perceptions for all students in both categories were analyzed and supported by historical data and students' feedback. Results: The whole revenue estimation for unaffiliated students' fees during one program was found higher than the total estimated benefits from forecasting. The total monetary cost estimation was higher than the integrated Diploma's cost during the program that was paid once. The ROI is (-7.73%). The HAPU percentage was lower than the MOH benchmark. The highest mean was for the personal attitude to patient safety, and the lowest was for knowledge of error and patient safety (4.05 ± 0.66 and 3.33 ± 0.74, respectively). Conclusions: The study indicated a negative value from business perspectives; however, the projected multiple intangible benefits on education and training of the health sector are significant.
ABSTRACT
OBJECTIVES: This study examines the Saudi Arabian population's willingness to participate in clinical trials for the coronavirus disease 2019 (COVID-19) vaccine, comparing recovered cases' willingness with that of healthy volunteers. METHODS: A case-control study was conducted on the Saudi Arabian population during September 2020. The data were collected from recovered COVID-19 participants as the case group, and healthy volunteers as the control group. RESULTS: The data showed that 42.2% (n = 315) of recovered COVID-19 cases were more willing to participate in the COVID-19 vaccine trial than healthy volunteers (299; 38.1%) with a p < 0.001. The proportion of the participants who were willing to donate plasma was significantly higher among recovered participants, 84.2% (n = 112), than healthy volunteers, 76.3% (n = 87), with a p < 0.0001. The most significant factor responsible for a willingness to participate was the belief that vaccine discovery would help scientific developments (r = 0.525 and 0.465 for case and control, respectively). In comparison, significant reasons behind the unwillingness to participate were the risk of exposure to an unproven vaccine, r = 0.377 and 0.497 for case and control, respectively (p < 0.001), and a discomfort with being treated as an experimental subject (r = 0.275 and 0.374 for case and control, respectively). CONCLUSIONS: The differences in readiness toward the COVID-19 vaccine trial in our study does not indicate any passive exposure of participants to an unproven clinical trial vaccine, nor does it shed light on well-informed risk-related decisions. However, certain factors can significantly influence decision-making while contributing toward clinical research. This study's results must not be used for the individuals' recruitment bias in a COVID-19 vaccine trial.
ABSTRACT
OBJECTIVE: To assess the perspective of Saudi women in the Makkah region on breast cancer awareness and early detection. MATERIALS AND METHODS: A mixed method study was conducted among 25-65 years old healthy Saudi females from Makkah region during the awareness campaign in October 2014. The participants were recruited by personal invitations at the women's places of work and social gatherings. The initial invitations were issued by either the research coordinator or the investigator. All women were asked to complete a short questionnaire on basic knowledge on breast cancer. This was followed by focus group discussions. All interviews were carried out by female breast cancer consultant oncologists. All discussion transcripts were summarized and categorized into main themes; data presented as frequencies and percentages. RESULTS: Forty Saudi females, aged 25-65 years, were included in the study. Nearly 38% of them had never attended any awareness campaign on breast cancer. Only 10% of the participants correctly answered all five basic questions on the risk and early detection of breast cancer; 63% of the women had never been taught breast self-examination. Participants' perception was discussed in five focus groups. Four themes were identified during the discussions: knowledge about breast cancer and screening; resources of breast cancer awareness; social support for access to awareness program; and beliefs on breast cancer and early detection. CONCLUSION: We recommend that strategies on breast cancer awareness in our population should focus on early detection by improving the knowledge and skills of women. These strategies should include programs widely accessible through primary health-care centers and other health-care institutions. In addition, we recommend that physicians and family members should be involved in these programs.
